Phibro Animal Health Raises FY2026 Adj EPS Guidance from $2.64-$2.81 to $2.93-$3.10 vs $2.74 Est; Raises FY2026 Sales Guidance from $1.430B-$1.480B to $1.450B-$1.500B vs $1.466B Est
Benzinga Newsdesk 9 months ago
NewsGuidance
Phibro Animal Health (NASDAQ:PAHC) raises FY2026 Adj EPS guidance from $2.64-$2.81 to $2.93-$3.10 vs $2.74 analyst estimate. Raises FY2026 sales outlook from $1.430 billion-$1.480 billion to $1.450 billion-$1.500 billion
Phibro Animal Health (NASDAQ:PAHC) raises FY2026 Adj EPS guidance from $2.64-$2.81 to $2.93-$3.10 vs $2.74 analyst estimate. Raises FY2026 sales outlook from $1.430 billion-$1.480 billion to $1.450 billion-$1.500 billion vs $1.466 billion estimate.